Clinical Trials Logo

Clinical Trial Summary

This study aimed to determine the therapeutic effectiveness of different machines in intense pulsed light (IPL) treatment of meibomian gland dysfunction (MGD). Subjects diagnosed with MGD underwent three sessions of IPL treatment in a control (M22) treatment group or experimental (OPL-I) treatment group and were followed up three to four weeks after each session. Tear breakup time (TBUT), meibomian gland secretion scores (MGSS), meibomian gland meibum scores (MGMS), corneal fluorescein staining (CFS) scores, and the Standard Patient Evaluation of Eye Dryness (SPEED) was used to assess eye dryness signs and symptoms at baseline and follow-up visits.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06034626
Study type Interventional
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact
Status Completed
Phase Phase 3
Start date November 3, 2020
Completion date December 15, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03515187 - Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops Phase 3
Not yet recruiting NCT06468930 - Efficacy of Adjunctive Low-Level Light Therapy to Intense Pulsed Light for Meibomian Gland Dysfunction N/A
Recruiting NCT06324890 - PET-CT Imaging Features of Meibomian Glands
Completed NCT03104894 - The Effect of Meibomian Glands Massage on Signs and Symptoms of Dry Eye N/A
Completed NCT03888378 - Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction Phase 2
Recruiting NCT06287879 - Function and Morphological Characteristics of Meibomian Gland in Patients With Renal Anemia N/A